- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE unveils new cardiovascular ultrasound
At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial
At this months Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial tissue visualization technique called tissue tracking.
The tool aids cardiologists in the diagnosis and monitoring of coronary artery disease.
Vivid FiVe was preceded by the Vingmed System FiVe in GEs line of cardiovascular ultrasound products, and is an upgrade to this system. The Vivid FiVe includes three new features: tissue tracking, contrast imaging with real-time myocardial contrast, and four-dimensional imaging.
Tissue tracking provides more accurate imaging of the heart, contrast imaging allows clinicians to study myocardial perfusion, and 4-D imaging occurs when clinicians apply 2-D digital data to construct a 4-D model of cardiac functions.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
